Tapewire

Nasdaq · USD

STIM

Neuronetics, Inc.

Export transactions ↓
Tapewire entity
6248
SEC CIK
0001227636
Parsed reports
328

Last 12 months

Inside the activity.

14 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202606
Mar 202685
Apr 202620
May 202620
Jun 202600
Jul 202610
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 30, 2019 Filed Nov 1, 2019 20:10 UTC GrantCommon Stock 3,244 Not disclosed Not disclosed
Disclosure

SEC source: 0001192482-19-000377 · edgar.xml · nonDerivative · entry 1

CONLEY SHERYL L · CIK 0001238659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,244

F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) October 30, 2020, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 13:16 UTC GrantCommon Stock 1,957 $8.30 $16,243.10
Disclosure

SEC source: 0001209191-19-051999 · doc4.xml · nonDerivative · entry 1

JAEGER WILFRED E · CIK 0001190474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,577

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 13:15 UTC GrantCommon Stock 1,656 $8.30 $13,744.80
Disclosure

SEC source: 0001209191-19-051998 · doc4.xml · nonDerivative · entry 1

CAMPE STEPHEN M · CIK 0001206614 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,410

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

F2 · ownership.direct: Mr. Stephen M. Campe is an advisor to an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer").

F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose.

F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose.

Read SEC document
September 04, 2019 Filed Sep 6, 2019 20:49 UTC
Thatcher ChristopherDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001209191-19-048778 · doc4.xml · derivative · entry 3

Thatcher Christopher · CIK 0001744956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,297

Underlying: Common Stock · 20,000 shares

Expires 2025-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
September 04, 2019 Filed Sep 6, 2019 20:49 UTC
Thatcher ChristopherDirector · President and CEO
SaleCommon Stock 20,000 $10.74 $214,700.00
Disclosure

SEC source: 0001209191-19-048778 · doc4.xml · nonDerivative · entry 2

Thatcher Christopher · CIK 0001744956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,811

F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
September 04, 2019 Filed Sep 6, 2019 20:49 UTC
Thatcher ChristopherDirector · President and CEO
Exercise / conversionCommon Stock 20,000 $0.87 $17,400.00
Disclosure

SEC source: 0001209191-19-048778 · doc4.xml · nonDerivative · entry 1

Thatcher Christopher · CIK 0001744956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 24, 2019 Filed Jul 26, 2019 22:05 UTC
Harper GregoryVP of R&D, Ops. and Prod. Dev.
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 19,213 $0.00 Strike: $3.19 $0.00
Disclosure

SEC source: 0001209191-19-043415 · doc4.xml · derivative · entry 2

Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,323

Underlying: Common Stock · 19,213 shares

Expires 2026-10-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on September 12, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
July 24, 2019 Filed Jul 26, 2019 22:05 UTC
Harper GregoryVP of R&D, Ops. and Prod. Dev.
Exercise / conversionCommon Stock 19,213 $3.19 $61,289.47
Disclosure

SEC source: 0001209191-19-043415 · doc4.xml · nonDerivative · entry 1

Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 16:33 UTC
Furlong StephenCFO and Secretary
GrantEmployee Stock Option (right to buy) · Derivative 117,845 $0.00 Strike: $11.48 $0.00
Disclosure

SEC source: 0001209191-19-043047 · doc4.xml · derivative · entry 2

Furlong Stephen · CIK 0001783360 · CFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,845

Underlying: Common Stock · 117,845 shares

Expires 2029-07-22

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on July 22, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 16:33 UTC
Furlong StephenCFO and Secretary
GrantCommon Stock 60,975 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-043047 · doc4.xml · nonDerivative · entry 1

Furlong Stephen · CIK 0001783360 · CFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,975

F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of July 22, 2020 and July 22, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on July 22, 2022, subject to Reporting Person continuing to provide service through each such date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:16 UTC GrantCommon Stock 1,298 $12.51 $16,237.98
Disclosure

SEC source: 0001209191-19-040460 · doc4.xml · nonDerivative · entry 1

JAEGER WILFRED E · CIK 0001190474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,620

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:15 UTC GrantCommon Stock 1,099 $12.51 $13,748.49
Disclosure

SEC source: 0001209191-19-040453 · doc4.xml · nonDerivative · entry 1

CAMPE STEPHEN M · CIK 0001206614 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,754

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

F2 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer").

F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose.

F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:50 UTC
MUIR GLENN PDirector
GrantStock Option (right to buy) · Derivative 7,347 $0.00 Strike: $13.43 $0.00
Disclosure

SEC source: 0001209191-19-033453 · doc4.xml · derivative · entry 2

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,347

Underlying: Common Stock · 7,347 shares

Expires 2029-05-27

F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:50 UTC
MUIR GLENN PDirector
GrantCommon Stock 3,723 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-033453 · doc4.xml · nonDerivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,723

F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:47 UTC GrantStock Option (right to buy) · Derivative 7,347 $0.00 Strike: $13.43 $0.00
Disclosure

SEC source: 0001209191-19-033450 · doc4.xml · derivative · entry 2

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,347

Underlying: Common Stock · 7,347 shares

Expires 2029-05-27

F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:47 UTC GrantCommon Stock 3,723 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-033450 · doc4.xml · nonDerivative · entry 1

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,437

F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:51 UTC GrantStock Option (right to buy) · Derivative 7,347 $0.00 Strike: $13.43 $0.00
Disclosure

SEC source: 0001209191-19-033455 · doc4.xml · derivative · entry 2

CAMPE STEPHEN M · CIK 0001206614 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,347

Underlying: Common Stock · 7,347 shares

Expires 2029-05-27

F6 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F3 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer").

F4 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose.

F5 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:51 UTC GrantCommon Stock 3,723 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-033455 · doc4.xml · nonDerivative · entry 1

CAMPE STEPHEN M · CIK 0001206614 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,655

F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer").

F4 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose.

F5 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:49 UTC GrantStock Option (right to buy) · Derivative 7,347 $0.00 Strike: $13.43 $0.00
Disclosure

SEC source: 0001209191-19-033452 · doc4.xml · derivative · entry 2

Farley Brian E · CIK 0001306117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,347

Underlying: Common Stock · 7,347 shares

Expires 2029-05-27

F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:49 UTC GrantCommon Stock 5,584 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-033452 · doc4.xml · nonDerivative · entry 1

Farley Brian E · CIK 0001306117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,606

F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:48 UTC GrantStock Option (right to buy) · Derivative 7,347 $0.00 Strike: $13.43 $0.00
Disclosure

SEC source: 0001209191-19-033451 · doc4.xml · derivative · entry 2

JAEGER WILFRED E · CIK 0001190474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,347

Underlying: Common Stock · 7,347 shares

Expires 2029-05-27

F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

Read SEC document
May 28, 2019 Filed May 30, 2019 20:48 UTC GrantCommon Stock 3,723 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-033451 · doc4.xml · nonDerivative · entry 1

JAEGER WILFRED E · CIK 0001190474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,322

F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2019 Filed May 23, 2019 20:54 UTC
Guthrie DanielChief Commercial Officer
SaleCommon Stock 3,685 $14.53 $53,543.05
Disclosure

SEC source: 0001209191-19-032311 · doc4.xml · nonDerivative · entry 1

Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,574

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.30 to $14.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote (1) to this Form 4.

Read SEC document
May 14, 2019 Filed May 14, 2019 17:49 UTC
Donato PeterVice President and CFO
SaleCommon Stock 8,032 $14.90 $119,676.80
Disclosure

SEC source: 0001209191-19-029741 · doc4.xml · nonDerivative · entry 2

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,987

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.445 to $15.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 13, 2019 Filed May 14, 2019 17:49 UTC
Donato PeterVice President and CFO
SaleCommon Stock 563 $15.40 $8,670.20
Disclosure

SEC source: 0001209191-19-029741 · doc4.xml · nonDerivative · entry 1

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,019

Read SEC document
May 10, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
SaleCommon Stock 706 $15.30 $10,801.80
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 6

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,582

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.435 inclusive.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 24,051 $0.00 Strike: $3.19 $0.00
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 9

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,662

Underlying: Common Stock · 24,051 shares

Expires 2027-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,672 $0.00 Strike: $4.64 $0.00
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 8

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,014

Underlying: Common Stock · 7,672 shares

Expires 2028-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on March 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 6,905 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 7

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,667

Underlying: Common Stock · 6,905 shares

Expires 2027-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
SaleCommon Stock 1,878 $15.67 $29,428.26
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 5

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,288

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.50 to $15.935 inclusive.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
SaleCommon Stock 20,469 $15.23 $311,742.87
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 4

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $15.4925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
Exercise / conversionCommon Stock 24,051 $3.19 $76,722.69
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 3

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
Exercise / conversionCommon Stock 7,672 $4.64 $35,598.08
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 2

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2019 Filed May 13, 2019 18:33 UTC
Donato PeterVice President and CFO
Exercise / conversionCommon Stock 6,905 $2.32 $16,019.60
Disclosure

SEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 1

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2019 Filed Apr 25, 2019 21:37 UTC GrantCommon Stock 1,584 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-026015 · doc4.xml · nonDerivative · entry 1

Farley Brian E · CIK 0001306117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,022

F1 · kind: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of July 26, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service.

F2 · price: Each RSU represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 22, 2019 Filed Apr 23, 2019 20:55 UTC
Harper GregoryVP of R&D, Ops. and Prod. Dev.
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $3.19 $0.00
Disclosure

SEC source: 0001209191-19-025592 · doc4.xml · derivative · entry 2

Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,536

Underlying: Common Stock · 35,000 shares

Expires 2026-10-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on September 12, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
April 22, 2019 Filed Apr 23, 2019 20:55 UTC
Harper GregoryVP of R&D, Ops. and Prod. Dev.
Exercise / conversionCommon Stock 35,000 $3.19 $111,650.00
Disclosure

SEC source: 0001209191-19-025592 · doc4.xml · nonDerivative · entry 1

Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 08, 2019 Filed Apr 8, 2019 22:26 UTC
Thatcher ChristopherDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001209191-19-024035 · doc4.xml · derivative · entry 3

Thatcher Christopher · CIK 0001744956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,297

Underlying: Common Stock · 15,000 shares

Expires 2025-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
April 08, 2019 Filed Apr 8, 2019 22:26 UTC
Thatcher ChristopherDirector · President and CEO
SaleCommon Stock 15,000 $16.82 $252,300.00
Disclosure

SEC source: 0001209191-19-024035 · doc4.xml · nonDerivative · entry 2

Thatcher Christopher · CIK 0001744956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,811

F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.545 to $16.955 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 08, 2019 Filed Apr 8, 2019 22:26 UTC
Thatcher ChristopherDirector · President and CEO
Exercise / conversionCommon Stock 15,000 $0.87 $13,050.00
Disclosure

SEC source: 0001209191-19-024035 · doc4.xml · nonDerivative · entry 1

Thatcher Christopher · CIK 0001744956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 17:31 UTC
HUNT RONALDDirector · 10% owner
GrantCommon Stock 847 $14.75 $12,493.25
Disclosure

SEC source: 0001209191-19-023352 · doc4.xml · nonDerivative · entry 1

HUNT RONALD · CIK 0001247851 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 847

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 21:34 UTC GrantCommon Stock 932 $14.75 $13,747.00
Disclosure

SEC source: 0001209191-19-023362 · doc4.xml · nonDerivative · entry 1

JAEGER WILFRED E · CIK 0001190474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,599

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 21:32 UTC GrantCommon Stock 932 $14.75 $13,747.00
Disclosure

SEC source: 0001209191-19-023358 · doc4.xml · nonDerivative · entry 1

CAMPE STEPHEN M · CIK 0001206614 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,932

F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.

F2 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer").

F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose.

F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 19:11 UTC
Donato PeterVice President and CFO
GrantEmployee Stock Option (right to buy) · Derivative 24,652 $0.00 Strike: $16.42 $0.00
Disclosure

SEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 8

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,652

Underlying: Common Stock · 24,652 shares

Expires 2029-03-08

F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 19:11 UTC
Donato PeterVice President and CFO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 8,177 $0.00 Strike: $3.19 $0.00
Disclosure

SEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 7

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,713

Underlying: Common Stock · 8,177 shares

Expires 2027-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 19:11 UTC
Donato PeterVice President and CFO
GrantCommon Stock 14,007 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 5

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,007

F3 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date.

F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 19:11 UTC
Donato PeterVice President and CFO
SaleCommon Stock 8,177 $16.01 $130,913.77
Disclosure

SEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 4

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.085 inclusive.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 19:11 UTC
Donato PeterVice President and CFO
Exercise / conversionCommon Stock 8,177 $3.19 $26,084.63
Disclosure

SEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 3

Donato Peter · CIK 0001408320 · Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 23:13 UTC
Harper GregoryVP of R&D, Ops. and Prod. Dev.
GrantEmployee Stock Option (right to buy) · Derivative 19,829 $0.00 Strike: $16.42 $0.00
Disclosure

SEC source: 0001209191-19-018612 · doc4.xml · derivative · entry 2

Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,829

Underlying: Common Stock · 19,829 shares

Expires 2029-03-08

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Read SEC document
March 08, 2019 Filed Mar 11, 2019 23:13 UTC
Harper GregoryVP of R&D, Ops. and Prod. Dev.
GrantCommon Stock 11,267 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-018612 · doc4.xml · nonDerivative · entry 1

Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,267

F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.